BioRestorative Therapies Inc (NASDAQ: BRTX) emerged from chapter on 11/16/20 with the commons intact, it had its up and down within the OTC attributable to its money owed that former CEO of 10 years took, with convertible notes at 50%-60% low cost to market that led to declined worth, they’re all disclosed in earlier fillings . Only a transient abstract, New CEO, Lance Alstodt was appointed for reorganization, Mr. Alstodt brings over 25 years of expertise in main medical know-how and life sciences corporations in operations, capital elevating actions, technique, and mergers and acquisitions. Auctus Administration lend them cash to proceed working and attempt to begin the trial and uplist the place establishment can put money into the corporate and lift funding for Part 2 Scientific Trials. With all of the warrants and debt it had throughout chapter, there was no different selections however to do RS (positively hurts the outdated OTC shareholders) however in conjunction to the RS, CEO managed to get an settlement for warrants and customary shares to be locked up in sure situations, please learn fillings. It was aggressively accomplished so, to verify it meets its requirement in NASDAQ and traders , as a result of it might have been worse, one other bk, however no, it met NASDAQ requirement and it was uplisted on 11/4/21. This is sort of a Phoenix rising from the ashes.
Can we skip to the great half!
Alongside the best way to NASDAQ it had appointed two new unbiased members to its Board of Administrators with trade and medical gadget expertise: Patrick F. Williams, Chief Monetary Officer at STAAR Surgical (Market Cap of 5.4B and buying and selling at $110), and David Rosa, President and Chief Government Officer at NeuroOne and a brand new CFO Robert Kristal with an in depth array of strategic and monetary markets expertise to the Firm, together with a background in advising world public life sciences corporations in company finance, operations administration programs, and strategic collaborations. Mr. Kristal is an skilled and versatile Wall Avenue and Bay St. skilled who has constructed groups in each institutional gross sales and fairness analysis at corporations which have developed a notable presence in healthcare analysis and capital market actions. Most lately he served because the Head of Analysis for H.C. Wainwright.
Institutional Buyers/ Hedge Funds coming in filling their 13G.
Altium Capital Administration invested $2M into Biorestorative Therapies.
Guidelines within the close to time period objectives.
◾️We will anticipate extra SC 13G’s to be rolling out. (Sabby and Altium solely has been filed anticipate extra to come back)
◾️Information of contract with a CRO. (PR out)
◾️Information of pre-clinical animal examine for metabolic program.
◾️Issuance of latest patents regarding metabolic program.
◾️Information of product manufacturing clearance.
◾️Information of established scientific websites for BRTX-100 scientific trial.
BRTX-100 stem cell product prepared for P-2, Used efficiently in Cayman Islands (FDA approval not required). Regenexx licenses IP to BRTX who licenses the entire process again to Rgnx and bought as Regenexx-C Intradiscal.
Regenexx-C Intradiscal — Regenexx Cayman Orthopedic
Some heavy hitters have gone there for therapy … well-known Dr. Josh Axe and many professional athletes have used Regenexx-C/Intradiscal for joints all through physique, identical process (BRTX searching for disc approval) https://regenexxcayman.com/patient-testimonials/
The science is sound, and is already used on a regular basis to enhance lives, simply at $20G+ a pop, not insurance coverage lined and never in US but. FDA approval would change that.
Think about all of the areas BRTX100 can attain as soon as all trials are accomplished and FDA approval. Beneath is the situation of Regenexx. Basically BRTX distribution community is being established. Not recommendation, nonetheless dangers, do your personal due diligence.
Biorestorative have research that present normoxic vs hypoxic cells for his or her product BRTX100. 50% cell dying in normoxic. $BRTX enter 40mm cells. $MESO Mesoblast can solely do 6mm cells. Sturdy affected person desire for ones personal cell vs cadaver. No animal merchandise in BRTX. BRTX use platelet lysate, they use H acid. Lysate additionally has sure vitamins to assist cell survival and construction.
Mesoblast Market cap is $800M simply European market, BioRestorative is in a early stage biotech firm and has a whole lot of room to develop, US Market.
Lately downgraded partnership deal after Part 3 preliminary outcomes not reaching its major end result measure between the therapy teams.
With BRTX having extra benefit in utilizing hypoxic MSCs and sufferers personal cells, BioRestorative stands a shot. #DoTheMath
Low float firm! Totally Funded for Part 2 and Trials beginning!
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic merchandise utilizing cell and tissue protocols, primarily involving grownup stem cells. Our two core applications, as described beneath, relate to the therapy of disc/backbone illness and metabolic problems:
• Disc/Backbone Program (brtxDISC™): Our lead cell remedy candidate, BRTX-100, is a product formulated from autologous (or an individual’s personal) cultured mesenchymal stem cells collected from the affected person’s bone marrow. We intend that the product might be used for the non-surgical therapy of painful lumbosacral disc problems or as a complementary therapeutic to a surgical process. The BRTX-100 manufacturing course of makes use of proprietary know-how and includes accumulating a affected person’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient process, BRTX-100 is to be injected by a doctor into the affected person’s broken disc. The therapy is meant for sufferers whose ache has not been alleviated by non-invasive procedures and who doubtlessly face the prospect of surgical procedure. We now have obtained authorization from the Meals and Drug Administration to start a Part 2 scientific trial utilizing BRTX-100 to deal with persistent decrease again ache arising from degenerative disc illness.
• Metabolic Program (ThermoStem®): We’re growing a cell-based remedy candidate to focus on weight problems and metabolic problems utilizing brown adipose (fats) derived stem cells to generate brown adipose tissue (“BAT”). BAT is meant to imitate naturally occurring brown adipose depots that regulate metabolic homeostasis in people. Preliminary preclinical analysis signifies that elevated quantities of brown fats in animals could also be chargeable for extra caloric burning in addition to diminished glucose and lipid ranges. Researchers have discovered that folks with greater ranges of brown fats might have a diminished danger for weight problems and diabetes.
BRTX has quite a few patents around the globe.
Sec Report- https://sec.report/CIK/0001505497/1#paperwork
Public Presentation -https://www.biorestorative.com/ir/wp-content/uploads/2021/06/BRTX-EG-Investor-Presentation-Remaining.pdf
Rising Development with BioRestorative Therapies- https://www.youtube.com/watch?v=HfQ8R0oAh7M –
Some again tales to concentrate on brtx has some a number of bear basher however this basher stands out essentially the most. The corporate would not have been stronger as frequent would have been worn out if it went to the arms of the IP legal professional.
Full Disclosure: Nothing on this submit ought to ever be thought of to be *recommendation*, analysis, or an invite to purchase or promote any securities or funding product. I don’t present private funding recommendation and I’m not a certified licensed funding advisor. All info discovered right here, together with any concepts, opinions, views, predictions, forecasts, commentaries, options, or inventory picks, expressed or implied herein, are for informational, leisure or instructional functions solely and shouldn’t be construed as private funding recommendation. Whereas the knowledge supplied is believed to be correct, it could embody errors or inaccuracies. I can’t and can’t be held accountable for any actions you’re taking on account of something you learn right here. **Conduct your personal due diligence**, or seek the advice of a licensed monetary advisor or dealer earlier than making any and all funding selections.